Keywords: Daiichi Sankyo, PharmaForce, Luitpold, M&A, Alcon, Novartis

Daiichi Sankyo acquires PharmaForce; Alcon dissatisfied with Novartis offer

Article | 06 January 2010

Japanese drug major Daiichi Sankyo’s US unit, Luitpold Pharmaceuticals, has acquired PharmaForce, a privately-held, fully integrated specialty injectable pharmaceutical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in